Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Proc Natl Acad Sci U S A ; 103(5): 1440-5, 2006 Jan 31.
Artigo em Inglês | MEDLINE | ID: mdl-16434471

RESUMO

The goal of this study was to elucidate the molecular mechanism by which type I IFN inhibits assembly and release of HIV-1 virions. Our study revealed that the IFN-induced ubiquitin-like protein ISG15 mimics the IFN effect and inhibits release of HIV-1 virions without having any effect on the synthesis of HIV-1 proteins in the cells. ISG15 expression specifically inhibited ubiquitination of Gag and Tsg101 and disrupted the interaction of the Gag L domain with Tsg101, but conjugation of ISG15 to Gag or Tsg101 was not detected. The inhibition of Gag-Tsg101 interaction was also detected in HIV-1 infected, IFN-treated cells. Elimination of ISG15 expression by small interfering RNA reversed the IFN-mediated inhibition of HIV-1 replication and release of virions. These results indicated a critical role for ISG15 in the IFN-mediated inhibition of late stages of HIV-1 assembly and release and pointed to a mechanism by which the innate antiviral response targets the cellular endosomal trafficking pathway used by HIV-1 to exit the cell. Identification of ISG15 as the critical component in IFN-mediated inhibition of HIV-1 release advances the understanding of the IFN-mediated inhibition of HIV-1 replication and uncovers a target for the anti HIV-1 therapy.


Assuntos
Antivirais/farmacologia , Citocinas/fisiologia , HIV-1/metabolismo , Ubiquitina/metabolismo , Western Blotting , Linhagem Celular , Citocinas/metabolismo , DNA Complementar/metabolismo , Proteínas de Ligação a DNA/química , Relação Dose-Resposta a Droga , Complexos Endossomais de Distribuição Requeridos para Transporte , Endossomos/metabolismo , Produtos do Gene gag/metabolismo , Vetores Genéticos , Humanos , Imunoprecipitação , Lentivirus/genética , Modelos Estatísticos , Plasmídeos/metabolismo , RNA Interferente Pequeno/metabolismo , Fatores de Tempo , Fatores de Transcrição/química , Transfecção , Ubiquitina/química , Ubiquitinas/metabolismo , Ubiquitinas/fisiologia , Replicação Viral
2.
Biochem Biophys Res Commun ; 330(4): 1199-204, 2005 May 20.
Artigo em Inglês | MEDLINE | ID: mdl-15823570

RESUMO

Escherichia coli K1 is the most common gram-negative bacterium causing neonatal meningitis. The outer membrane protein A (OmpA) assembles a beta-barrel structure having four surface-exposed loops in E. coli outer membrane. OmpA of meningitis-causing E. coli K1 is shown to contribute to invasion of the human brain microvascular endothelial cells (HBMEC), the main cellular component of the blood-brain barrier (BBB). However, the direct evidence of OmpA protein interacting with HBMEC is not clear. In this study, we showed that OmpA protein, solubilized from the outer membrane of E. coli, adhered to HBMEC surface. To verify OmpA interaction with the HBMEC, we purified N-terminal membrane-anchoring beta-barrel domain of OmpA and all surface-exposed loops deleted OmpA proteins, and showed that the surface-exposed loops of OmpA were responsible for adherence to HBMEC. These findings indicate that the OmpA is the adhesion molecule with HBMEC and the surface-exposed loops of OmpA are the determinant of this interaction.


Assuntos
Proteínas da Membrana Bacteriana Externa/metabolismo , Encéfalo/metabolismo , Células Endoteliais/metabolismo , Endotélio Vascular/metabolismo , Proteínas de Escherichia coli/metabolismo , Barreira Hematoencefálica/metabolismo , Encéfalo/irrigação sanguínea , Células Cultivadas , Endotélio Vascular/citologia , Escherichia coli/metabolismo , Humanos , Microcirculação/metabolismo , Ligação Proteica
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...